GlycoMimetics (GLYC) Stock Chart & Stock Price History $0.17 -0.01 (-3.51%) Closing price 04:00 PM EasternExtended Trading$0.17 0.00 (-0.23%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics Stock Price Performance The GlycoMimetics (GLYC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 34.18%, with a year-to-date return of -31.57%. In the past month, the stock has decreased 29.06%, reflecting recent market activity. As of the latest close, GlycoMimetics traded at $0.18 with a market cap of $11.40 million and volume of 2.69 million shares. Five years ago, the stock traded at a split-adjusted price of $3.08, representing a 94.47% decrease over that period. At the time, it had a market cap of $128.57 million and a volume of 404,300 shares. Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-14.20%1 Month Performance-29.06%3 Month Performance-34.71%Year-To-Date Performance-31.57%1 Year Performance-34.18%5 Year Performance-94.47% GLYC Stock Chart for Tuesday, June, 10, 2025 GLYC Chart by TradingView GlycoMimetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$0.18$0.17-3.51%$0.18$0.151.78 million shs$11.00 million06/09/2025$0.19$0.18-8.88%$0.18$0.172.69 million shs$11.40 million06/06/2025$0.20$0.19-2.42%$0.21$0.1858.43 million shs$12.51 million06/05/2025$0.21$0.20-5.43%$0.21$0.2024.72 million shs$12.82 million06/04/2025$0.21$0.21+0.48%$0.22$0.20302,013 shs$13.55 million06/03/2025$0.20$0.21+3.47%$0.21$0.20243,845 shs$13.49 million06/02/2025$0.21$0.20-3.67%$0.22$0.20450,756 shs$13.04 million05/30/2025$0.21$0.21-1.64%$0.22$0.20586,195 shs$13.53 million05/29/2025$0.22$0.21-2.29%$0.22$0.20401,765 shs$13.76 million05/28/2025$0.23$0.22-4.63%$0.23$0.20792,988 shs$14.08 million Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$0.24$0.23-6.31%$0.25$0.22536,863 shs$14.77 million05/26/2025$0.24$0.24$0.25$0.24124,394 shs$15.76 million05/23/2025$0.25$0.24-1.53%$0.25$0.24124,394 shs$15.76 million05/22/2025$0.25$0.25-0.08%$0.25$0.2483,477 shs$16.00 million05/21/2025$0.26$0.25-5.16%$0.27$0.25169,434 shs$16.02 million05/20/2025$0.26$0.26+0.73%$0.28$0.25320,314 shs$16.89 million05/19/2025$0.25$0.26+5.18%$0.26$0.23133,353 shs$16.77 million05/16/2025$0.25$0.25-1.12%$0.27$0.25173,587 shs$15.94 million05/15/2025$0.24$0.25+4.52%$0.25$0.23770,809 shs$16.12 million05/14/2025$0.25$0.24-5.50%$0.27$0.23565,330 shs$15.42 million05/13/2025$0.26$0.25-1.52%$0.26$0.25282,808 shs$16.32 million05/12/2025$0.24$0.26+6.91%$0.26$0.24455,119 shs$16.57 million05/09/2025$0.24$0.24-0.74%$0.26$0.24135,954 shs$15.50 million Related Companies RenovoRx Stock Price Chart Annovis Bio Stock Price Chart Prelude Therapeutics Stock Price Chart Adverum Biotechnologies Stock Price Chart Actinium Pharmaceuticals Stock Price Chart Applied Therapeutics Stock Price Chart Shattuck Labs Stock Price Chart Verrica Pharmaceuticals Stock Price Chart Renovaro Stock Price Chart Cue Biopharma Stock Price Chart Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLYC) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Urgent Crypto Market Alert The last time we saw this pattern, early investors made fortunes...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we...Weiss Ratings | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLYC Stock Free GLYC Stock Alerts